Results 331 to 340 of about 1,451,429 (415)

Combined Transpetrosal Approach for Salvage Surgery in the Treatment of Recurrent and Advanced Nasopharyngeal Carcinoma: A Case Report. [PDF]

Cureus
Suyhogo S, Justo NJ, Dy JA.
europepmc   +1 more source

Nasopharyngeal carcinoma in Malaysian Chinese: occupational exposures to particles, formaldehyde and heat

, 2000
R. Warwick Armstrong, Peter B. Imrey, Munn Sann Lye, Michael J. Armstrong, M C Yu, Sofia Yuniar Sani   +5 more
openalex   +1 more source

Lung Adenocarcinoma With Extensive Vascular Invasion and Retinal Metastasis: A Case Report

Respirology Case Reports, Volume 13, Issue 6, June 2025.
This case report describes a unique presentation of lung adenocarcinoma with extensive vascular invasion and retinal metastasis, emphasising the role of molecular profiling and targeted therapy in managing advanced disease. ABSTRACT A 34‐year‐old Ghanaian male with no past medical history presented to our hospital with dyspnoea, left‐sided chest pain ...
Bassem Alhariri, Arwa Elfatih, Osman Osama Elhassan, Mohamed Elfatih, Aya Mohamed Kheir, Razan Elkhatib   +5 more
wiley   +1 more source

Plasma cfDNA VILL gene methylation as a diagnostic marker for nasopharyngeal carcinoma. [PDF]

Clin Epigenetics
Fu XY, Zhou ZY, Yang TY, Wen YJ, Liu DB, Zhou YB, Yue Y, Ye F, Huang ZX.   +8 more
europepmc   +1 more source

Induction Camrelizumab and Modified TPF (Nab‐Paclitaxel, Cisplatin, and S‐1) in Locoregionally Advanced Nasopharyngeal Carcinoma

Cancer Science, Volume 116, Issue 6, Page 1616-1626, June 2025.
ABSTRACT Induction chemo‐immunotherapy has emerged as a potential treatment option for locoregionally advanced nasopharyngeal carcinoma (LANPC). This study aimed to evaluate the efficacy and safety of camrelizumab combined with modified TPF (nab‐paclitaxel, cisplatin, and S‐1) as induction chemo‐immunotherapy in LANPC.
Yi‐Feng Yu, Ya‐Qing Dai, Zong‐Kai Zhang, Guan‐Zhong Lu, Qin Lin, San‐Gang Wu   +5 more
wiley   +1 more source

Association of the IL-10 and IL-18 polymorphisms with nasopharyngeal carcinoma risk. [PDF]

Front Oncol
Chen X, Zhang R, Xie H, Li S, Guo J, Wang Y.   +5 more
europepmc   +1 more source

Claudin‐11 Enhances Invasive and Metastatic Abilities of Small‐Cell Lung Cancer Through MT1‐MMP Activation

Cancer Science, Volume 116, Issue 6, Page 1773-1784, June 2025.
Claudin‐11 is a tight junction protein, and its role in small‐cell lung cancer (SCLC) remains unclear. This study showed that claudin‐11 was significantly upregulated in a highly metastatic subline of DMS273 SCLC cells, promoting cell invasion and metastasis through the activation of MT1‐MMP. Furthermore, claudin‐11 expression was detected in some SCLC
Shuichi Sakamoto, Hiroyuki Inoue, Takahisa Takino, Yasuko Kohda, Junjiro Yoshida, Shunichi Ohba, Ihomi Usami, Takeshi Suzuki, Manabu Kawada, Masanori Hatakeyama   +9 more
wiley   +1 more source

SYT7 accelerates nasopharyngeal carcinoma progression via ALDH1A3-mediated STAT3 signaling activation. [PDF]

Oncogenesis
Xu K, Kang Y, Wang J, Hou Y, Zheng W, Tian W, Liang C, Liu Y, Xiang X.   +8 more
europepmc   +1 more source

LTF as a Potential Predictive Biomarker for Durable Benefit From First‐Line Chemo‐Immunotherapy in Small Cell Lung Cancer

Cancer Science, Volume 116, Issue 6, Page 1522-1536, June 2025.
LTF as a potential biomarker for predicting the efficacy of chemo‐immunotherapy. ABSTRACT At present, only a limited fraction of patients with extensive‐stage small cell lung cancer (ES‐SCLC) achieve a sustained response to immune checkpoint blockade (ICB) therapy.
Shimo Shen, Yili Wu, Zhuowei Shao, You Li, Di Peng, Bing Li, Zhou Zhang, Shibo Wu   +7 more
wiley   +1 more source

Identification of RNA processing factor LSM5 as a new adverse biomarker in nasopharyngeal carcinoma. [PDF]

Sci Rep
Lin T, Deng L, Liu S, Chen Y, Tang Y, Zhou F, Gong G, He Y.   +7 more
europepmc   +1 more source